Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for MXI1_MYC_MYCN
Z-value: 4.10
Motif logo
Transcription factors associated with MXI1_MYC_MYCN
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MXI1
|
ENSG00000119950.16 | MAX interactor 1, dimerization protein |
|
MYC
|
ENSG00000136997.10 | MYC proto-oncogene, bHLH transcription factor |
|
MYCN
|
ENSG00000134323.10 | MYCN proto-oncogene, bHLH transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MXI1 | hg19_v2_chr10_+_111967345_111967442 | -0.97 | 4.7e-12 | Click! |
| MYC | hg19_v2_chr8_+_128748466_128748487 | -0.78 | 5.1e-05 | Click! |
| MYCN | hg19_v2_chr2_+_16080659_16080686 | 0.34 | 1.4e-01 | Click! |
Activity profile of MXI1_MYC_MYCN motif
Sorted Z-values of MXI1_MYC_MYCN motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_41903161 | 18.78 |
ENST00000602129.1
ENST00000593771.1 ENST00000596905.1 ENST00000221233.4 |
EXOSC5
|
exosome component 5 |
| chr2_+_198365122 | 17.59 |
ENST00000604458.1
|
HSPE1-MOB4
|
HSPE1-MOB4 readthrough |
| chr4_+_41258786 | 15.89 |
ENST00000503431.1
ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
| chr12_-_58146048 | 15.02 |
ENST00000547281.1
ENST00000546489.1 ENST00000552388.1 ENST00000540325.1 ENST00000312990.6 |
CDK4
|
cyclin-dependent kinase 4 |
| chr17_+_47074758 | 14.70 |
ENST00000290341.3
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1 |
| chrX_-_30326445 | 14.24 |
ENST00000378963.1
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1 |
| chrX_-_30327495 | 14.15 |
ENST00000453287.1
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1 |
| chr20_-_62129163 | 14.02 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr7_+_150759634 | 13.81 |
ENST00000392826.2
ENST00000461735.1 |
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2 |
| chr12_-_58146128 | 13.46 |
ENST00000551800.1
ENST00000549606.1 ENST00000257904.6 |
CDK4
|
cyclin-dependent kinase 4 |
| chr12_-_49318715 | 12.44 |
ENST00000444214.2
|
FKBP11
|
FK506 binding protein 11, 19 kDa |
| chr11_+_1244288 | 12.36 |
ENST00000529681.1
ENST00000447027.1 |
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming |
| chr10_+_101089107 | 12.24 |
ENST00000446890.1
ENST00000370528.3 |
CNNM1
|
cyclin M1 |
| chr12_-_117537240 | 12.04 |
ENST00000392545.4
ENST00000541210.1 ENST00000335209.7 |
TESC
|
tescalcin |
| chr17_+_47075023 | 12.04 |
ENST00000431824.2
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1 |
| chr19_+_2977444 | 11.77 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
| chr11_+_67776012 | 11.14 |
ENST00000539229.1
|
ALDH3B1
|
aldehyde dehydrogenase 3 family, member B1 |
| chr19_+_50180409 | 10.92 |
ENST00000391851.4
|
PRMT1
|
protein arginine methyltransferase 1 |
| chr16_+_2570340 | 10.66 |
ENST00000568263.1
ENST00000293971.6 ENST00000302956.4 ENST00000413459.3 ENST00000566706.1 ENST00000569879.1 |
AMDHD2
|
amidohydrolase domain containing 2 |
| chr12_+_54332535 | 10.30 |
ENST00000243056.3
|
HOXC13
|
homeobox C13 |
| chr10_+_101088836 | 10.23 |
ENST00000356713.4
|
CNNM1
|
cyclin M1 |
| chr15_+_67813406 | 10.18 |
ENST00000342683.4
|
C15orf61
|
chromosome 15 open reading frame 61 |
| chr11_-_117698787 | 10.00 |
ENST00000260287.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr1_+_186798073 | 9.89 |
ENST00000367466.3
ENST00000442353.2 |
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
| chr22_-_36903069 | 9.81 |
ENST00000216187.6
ENST00000423980.1 |
FOXRED2
|
FAD-dependent oxidoreductase domain containing 2 |
| chr17_+_42148225 | 9.72 |
ENST00000591696.1
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3 |
| chr17_+_72428218 | 9.60 |
ENST00000392628.2
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr10_-_69597810 | 9.53 |
ENST00000483798.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr11_-_64014379 | 9.37 |
ENST00000309318.3
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
| chr22_-_36903101 | 9.25 |
ENST00000397224.4
|
FOXRED2
|
FAD-dependent oxidoreductase domain containing 2 |
| chr21_+_38071430 | 9.13 |
ENST00000290399.6
|
SIM2
|
single-minded family bHLH transcription factor 2 |
| chr17_+_74732889 | 9.11 |
ENST00000591864.1
|
MFSD11
|
major facilitator superfamily domain containing 11 |
| chr17_+_49337881 | 9.00 |
ENST00000225298.7
|
UTP18
|
UTP18 small subunit (SSU) processome component homolog (yeast) |
| chr17_-_46688334 | 8.90 |
ENST00000239165.7
|
HOXB7
|
homeobox B7 |
| chr16_+_29911666 | 8.83 |
ENST00000563177.1
ENST00000483405.1 |
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
| chr10_-_69597915 | 8.78 |
ENST00000225171.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr17_-_15165854 | 8.75 |
ENST00000395936.1
ENST00000395938.2 |
PMP22
|
peripheral myelin protein 22 |
| chr12_+_52668394 | 8.74 |
ENST00000423955.2
|
KRT86
|
keratin 86 |
| chr16_+_29911864 | 8.67 |
ENST00000308748.5
|
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
| chr19_+_50180507 | 8.58 |
ENST00000454376.2
ENST00000524771.1 |
PRMT1
|
protein arginine methyltransferase 1 |
| chr3_-_142607740 | 8.54 |
ENST00000485766.1
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2 |
| chr15_+_50474412 | 8.43 |
ENST00000380902.4
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr11_-_117699413 | 8.34 |
ENST00000528014.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr1_-_212873267 | 8.24 |
ENST00000243440.1
|
BATF3
|
basic leucine zipper transcription factor, ATF-like 3 |
| chr8_+_142402089 | 8.19 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
| chr19_-_51307894 | 8.18 |
ENST00000597705.1
ENST00000391812.1 |
C19orf48
|
chromosome 19 open reading frame 48 |
| chr6_+_7727030 | 8.07 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
| chr17_+_1627834 | 8.02 |
ENST00000419248.1
ENST00000418841.1 |
WDR81
|
WD repeat domain 81 |
| chr7_+_150065278 | 7.98 |
ENST00000519397.1
ENST00000479668.1 ENST00000540729.1 |
REPIN1
|
replication initiator 1 |
| chr12_+_49658855 | 7.85 |
ENST00000549183.1
|
TUBA1C
|
tubulin, alpha 1c |
| chr17_+_72427477 | 7.81 |
ENST00000342648.5
ENST00000481232.1 |
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr1_-_21995794 | 7.81 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr19_-_51308175 | 7.81 |
ENST00000345523.4
|
C19orf48
|
chromosome 19 open reading frame 48 |
| chr20_-_2821271 | 7.78 |
ENST00000448755.1
ENST00000360652.2 |
PCED1A
|
PC-esterase domain containing 1A |
| chr21_+_33784670 | 7.65 |
ENST00000300255.2
|
EVA1C
|
eva-1 homolog C (C. elegans) |
| chr15_-_83316254 | 7.64 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr13_-_95953589 | 7.59 |
ENST00000538287.1
ENST00000376887.4 ENST00000412704.1 ENST00000536256.1 ENST00000431522.1 |
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
| chr19_+_34287751 | 7.42 |
ENST00000590771.1
ENST00000589786.1 ENST00000284006.6 ENST00000588881.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
| chr12_+_52695617 | 7.41 |
ENST00000293525.5
|
KRT86
|
keratin 86 |
| chr17_+_7590734 | 7.40 |
ENST00000457584.2
|
WRAP53
|
WD repeat containing, antisense to TP53 |
| chr11_+_844067 | 7.36 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
TSPAN4
|
tetraspanin 4 |
| chr19_+_42364313 | 7.36 |
ENST00000601492.1
ENST00000600467.1 ENST00000221975.2 |
RPS19
|
ribosomal protein S19 |
| chr6_-_33385854 | 7.35 |
ENST00000488478.1
|
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr22_-_38484922 | 7.24 |
ENST00000428572.1
|
BAIAP2L2
|
BAI1-associated protein 2-like 2 |
| chr10_-_95360983 | 7.22 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
| chr6_-_43197189 | 7.22 |
ENST00000509253.1
ENST00000393987.2 ENST00000230431.6 |
DNPH1
|
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
| chr19_+_41903709 | 7.21 |
ENST00000542943.1
ENST00000457836.2 |
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide |
| chr11_+_844406 | 7.16 |
ENST00000397404.1
|
TSPAN4
|
tetraspanin 4 |
| chr6_+_32811885 | 7.13 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
| chr19_-_38746979 | 7.04 |
ENST00000591291.1
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
| chr11_-_117698765 | 7.03 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr5_-_172755056 | 7.02 |
ENST00000520648.1
|
STC2
|
stanniocalcin 2 |
| chr6_-_39197226 | 6.90 |
ENST00000359534.3
|
KCNK5
|
potassium channel, subfamily K, member 5 |
| chr17_+_72428266 | 6.87 |
ENST00000582473.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr4_+_129732467 | 6.86 |
ENST00000413543.2
|
PHF17
|
jade family PHD finger 1 |
| chr20_+_44441215 | 6.85 |
ENST00000356455.4
ENST00000405520.1 |
UBE2C
|
ubiquitin-conjugating enzyme E2C |
| chr11_-_57282349 | 6.71 |
ENST00000528450.1
|
SLC43A1
|
solute carrier family 43 (amino acid system L transporter), member 1 |
| chr17_+_49230897 | 6.70 |
ENST00000393196.3
ENST00000336097.3 ENST00000480143.1 ENST00000511355.1 ENST00000013034.3 ENST00000393198.3 ENST00000608447.1 ENST00000393193.2 ENST00000376392.6 ENST00000555572.1 |
NME1
NME1-NME2
NME2
|
NME/NM23 nucleoside diphosphate kinase 1 NME1-NME2 readthrough NME/NM23 nucleoside diphosphate kinase 2 |
| chr10_-_76995675 | 6.69 |
ENST00000469299.1
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr12_-_49463753 | 6.66 |
ENST00000301068.6
|
RHEBL1
|
Ras homolog enriched in brain like 1 |
| chr16_+_770975 | 6.66 |
ENST00000569529.1
ENST00000564000.1 ENST00000219535.3 |
FAM173A
|
family with sequence similarity 173, member A |
| chr5_+_175298487 | 6.65 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
| chr2_-_165477971 | 6.64 |
ENST00000446413.2
|
GRB14
|
growth factor receptor-bound protein 14 |
| chrX_+_23685653 | 6.64 |
ENST00000379331.3
|
PRDX4
|
peroxiredoxin 4 |
| chr16_+_89642120 | 6.63 |
ENST00000268720.5
ENST00000319518.8 |
CPNE7
|
copine VII |
| chr12_+_58013693 | 6.61 |
ENST00000320442.4
ENST00000379218.2 |
SLC26A10
|
solute carrier family 26, member 10 |
| chr14_-_20923195 | 6.60 |
ENST00000206542.4
|
OSGEP
|
O-sialoglycoprotein endopeptidase |
| chr16_+_29466426 | 6.58 |
ENST00000567248.1
|
SLX1B
|
SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) |
| chr11_-_66336060 | 6.51 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
| chr11_+_1151573 | 6.48 |
ENST00000534821.1
ENST00000356191.2 |
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming |
| chr7_-_86849883 | 6.47 |
ENST00000433078.1
|
TMEM243
|
transmembrane protein 243, mitochondrial |
| chr6_+_151561085 | 6.43 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr7_+_94536898 | 6.43 |
ENST00000433360.1
ENST00000340694.4 ENST00000424654.1 |
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
| chr16_-_81129845 | 6.43 |
ENST00000569885.1
ENST00000566566.1 |
GCSH
|
glycine cleavage system protein H (aminomethyl carrier) |
| chr11_-_63933504 | 6.35 |
ENST00000255681.6
|
MACROD1
|
MACRO domain containing 1 |
| chr4_+_129732419 | 6.32 |
ENST00000510308.1
|
PHF17
|
jade family PHD finger 1 |
| chr2_+_46926048 | 6.31 |
ENST00000306503.5
|
SOCS5
|
suppressor of cytokine signaling 5 |
| chr5_-_174871136 | 6.30 |
ENST00000393752.2
|
DRD1
|
dopamine receptor D1 |
| chr8_+_145734433 | 6.30 |
ENST00000301327.4
|
MFSD3
|
major facilitator superfamily domain containing 3 |
| chr19_-_51307815 | 6.27 |
ENST00000601267.1
ENST00000593287.1 |
C19orf48
|
chromosome 19 open reading frame 48 |
| chr19_+_49458107 | 6.26 |
ENST00000539787.1
ENST00000345358.7 ENST00000391871.3 ENST00000415969.2 ENST00000354470.3 ENST00000506183.1 ENST00000293288.8 |
BAX
|
BCL2-associated X protein |
| chr15_-_72668185 | 6.24 |
ENST00000457859.2
ENST00000566304.1 ENST00000567159.1 ENST00000429918.2 |
HEXA
|
hexosaminidase A (alpha polypeptide) |
| chr11_-_61684962 | 6.23 |
ENST00000394836.2
|
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
| chr19_+_42364460 | 6.22 |
ENST00000593863.1
|
RPS19
|
ribosomal protein S19 |
| chr14_-_20922960 | 6.19 |
ENST00000553640.1
ENST00000488532.2 |
OSGEP
|
O-sialoglycoprotein endopeptidase |
| chr19_+_2476116 | 6.17 |
ENST00000215631.4
ENST00000587345.1 |
GADD45B
|
growth arrest and DNA-damage-inducible, beta |
| chr13_-_114107839 | 6.17 |
ENST00000375418.3
|
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
| chr22_+_35776828 | 6.17 |
ENST00000216117.8
|
HMOX1
|
heme oxygenase (decycling) 1 |
| chr19_+_10812108 | 6.14 |
ENST00000250237.5
ENST00000592254.1 |
QTRT1
|
queuine tRNA-ribosyltransferase 1 |
| chr19_-_39440495 | 6.11 |
ENST00000448145.2
ENST00000599996.1 |
SARS2
CTC-360G5.8
|
seryl-tRNA synthetase 2, mitochondrial Serine--tRNA ligase, mitochondrial |
| chr19_-_42806723 | 6.11 |
ENST00000262890.3
|
PAFAH1B3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) |
| chr11_+_809647 | 6.07 |
ENST00000321153.4
|
RPLP2
|
ribosomal protein, large, P2 |
| chr15_+_89164560 | 6.07 |
ENST00000379231.3
ENST00000559528.1 |
AEN
|
apoptosis enhancing nuclease |
| chr1_-_26233423 | 6.06 |
ENST00000357865.2
|
STMN1
|
stathmin 1 |
| chr1_+_149871171 | 6.05 |
ENST00000369150.1
|
BOLA1
|
bolA family member 1 |
| chr2_+_27440229 | 6.04 |
ENST00000264705.4
ENST00000403525.1 |
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
| chr19_-_10047219 | 6.03 |
ENST00000264833.4
|
OLFM2
|
olfactomedin 2 |
| chr11_+_69061594 | 6.01 |
ENST00000441339.2
ENST00000308946.3 ENST00000535407.1 |
MYEOV
|
myeloma overexpressed |
| chr6_-_33385655 | 5.95 |
ENST00000440279.3
ENST00000607266.1 |
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr17_+_42148097 | 5.92 |
ENST00000269097.4
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3 |
| chr2_+_198365095 | 5.83 |
ENST00000409468.1
|
HSPE1
|
heat shock 10kDa protein 1 |
| chr1_+_110162448 | 5.82 |
ENST00000342115.4
ENST00000469039.2 ENST00000474459.1 ENST00000528667.1 |
AMPD2
|
adenosine monophosphate deaminase 2 |
| chr19_-_51611623 | 5.82 |
ENST00000421832.2
|
CTU1
|
cytosolic thiouridylase subunit 1 |
| chr8_-_144691718 | 5.80 |
ENST00000377579.3
ENST00000433751.1 ENST00000220966.6 |
PYCRL
|
pyrroline-5-carboxylate reductase-like |
| chr14_-_24658053 | 5.75 |
ENST00000354464.6
|
IPO4
|
importin 4 |
| chr1_+_17248418 | 5.74 |
ENST00000375541.5
|
CROCC
|
ciliary rootlet coiled-coil, rootletin |
| chr3_-_127542051 | 5.74 |
ENST00000398104.1
|
MGLL
|
monoglyceride lipase |
| chr6_-_33385823 | 5.72 |
ENST00000494751.1
ENST00000374496.3 |
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr2_+_121493717 | 5.72 |
ENST00000418323.1
|
GLI2
|
GLI family zinc finger 2 |
| chr7_+_94537542 | 5.72 |
ENST00000433881.1
|
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
| chr11_+_57227981 | 5.70 |
ENST00000335099.3
|
RTN4RL2
|
reticulon 4 receptor-like 2 |
| chr7_-_86849836 | 5.65 |
ENST00000455575.1
|
TMEM243
|
transmembrane protein 243, mitochondrial |
| chr10_-_69597828 | 5.63 |
ENST00000339758.7
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr1_-_246729544 | 5.63 |
ENST00000544618.1
ENST00000366514.4 |
TFB2M
|
transcription factor B2, mitochondrial |
| chr1_-_26232951 | 5.61 |
ENST00000426559.2
ENST00000455785.2 |
STMN1
|
stathmin 1 |
| chr1_+_149871135 | 5.61 |
ENST00000369152.5
|
BOLA1
|
bolA family member 1 |
| chr20_-_62493217 | 5.58 |
ENST00000601296.1
|
C20ORF135
|
C20ORF135 |
| chr17_-_16256718 | 5.58 |
ENST00000476243.1
ENST00000299736.4 |
CENPV
|
centromere protein V |
| chr16_+_29467127 | 5.55 |
ENST00000344620.6
|
SULT1A4
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 |
| chr6_-_33385870 | 5.53 |
ENST00000488034.1
|
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr19_-_51307877 | 5.52 |
ENST00000597493.1
|
C19orf48
|
chromosome 19 open reading frame 48 |
| chr4_-_39529049 | 5.49 |
ENST00000501493.2
ENST00000509391.1 ENST00000507089.1 |
UGDH
|
UDP-glucose 6-dehydrogenase |
| chr1_-_11120057 | 5.47 |
ENST00000376957.2
|
SRM
|
spermidine synthase |
| chr21_+_33784957 | 5.46 |
ENST00000401402.3
ENST00000382699.3 |
EVA1C
|
eva-1 homolog C (C. elegans) |
| chr15_-_72668805 | 5.45 |
ENST00000268097.5
|
HEXA
|
hexosaminidase A (alpha polypeptide) |
| chr12_+_3069037 | 5.45 |
ENST00000397122.2
|
TEAD4
|
TEA domain family member 4 |
| chr1_+_45792541 | 5.44 |
ENST00000334815.3
|
HPDL
|
4-hydroxyphenylpyruvate dioxygenase-like |
| chr8_+_17354587 | 5.42 |
ENST00000494857.1
ENST00000522656.1 |
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
| chr14_-_20929624 | 5.41 |
ENST00000398020.4
ENST00000250489.4 |
TMEM55B
|
transmembrane protein 55B |
| chr17_+_34958001 | 5.41 |
ENST00000250156.7
|
MRM1
|
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) |
| chr20_+_44441304 | 5.41 |
ENST00000352551.5
|
UBE2C
|
ubiquitin-conjugating enzyme E2C |
| chr17_+_46970134 | 5.40 |
ENST00000503641.1
ENST00000514808.1 |
ATP5G1
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
| chr6_+_32811861 | 5.39 |
ENST00000453426.1
|
TAPSAR1
|
TAP1 and PSMB8 antisense RNA 1 |
| chr19_+_42363917 | 5.39 |
ENST00000598742.1
|
RPS19
|
ribosomal protein S19 |
| chr11_-_86383650 | 5.36 |
ENST00000526944.1
ENST00000530335.1 ENST00000543262.1 ENST00000524826.1 |
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial |
| chr16_+_67198683 | 5.35 |
ENST00000517685.1
ENST00000521374.1 ENST00000584272.1 |
HSF4
|
heat shock transcription factor 4 |
| chr6_-_33385902 | 5.34 |
ENST00000374500.5
|
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr7_-_2354099 | 5.34 |
ENST00000222990.3
|
SNX8
|
sorting nexin 8 |
| chr2_+_103236004 | 5.33 |
ENST00000233969.2
|
SLC9A2
|
solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 |
| chr16_+_2570431 | 5.31 |
ENST00000563556.1
|
AMDHD2
|
amidohydrolase domain containing 2 |
| chr15_+_50474385 | 5.27 |
ENST00000267842.5
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr19_-_5340730 | 5.25 |
ENST00000372412.4
ENST00000357368.4 ENST00000262963.6 ENST00000348075.2 ENST00000353284.2 |
PTPRS
|
protein tyrosine phosphatase, receptor type, S |
| chr17_+_48556158 | 5.25 |
ENST00000258955.2
|
RSAD1
|
radical S-adenosyl methionine domain containing 1 |
| chr3_-_127541679 | 5.21 |
ENST00000265052.5
|
MGLL
|
monoglyceride lipase |
| chr3_-_126076264 | 5.21 |
ENST00000296233.3
|
KLF15
|
Kruppel-like factor 15 |
| chr5_+_131630117 | 5.16 |
ENST00000200652.3
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4 |
| chr1_+_861095 | 5.15 |
ENST00000342066.3
|
SAMD11
|
sterile alpha motif domain containing 11 |
| chr8_+_103876528 | 5.14 |
ENST00000522939.1
ENST00000524007.1 |
KB-1507C5.2
|
HCG15011, isoform CRA_a; Protein LOC100996457 |
| chr3_-_127542021 | 5.14 |
ENST00000434178.2
|
MGLL
|
monoglyceride lipase |
| chr11_+_67159416 | 5.14 |
ENST00000307980.2
ENST00000544620.1 |
RAD9A
|
RAD9 homolog A (S. pombe) |
| chr17_-_7137857 | 5.11 |
ENST00000005340.5
|
DVL2
|
dishevelled segment polarity protein 2 |
| chr17_+_4853442 | 5.09 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
| chr17_-_4607335 | 5.09 |
ENST00000570571.1
ENST00000575101.1 ENST00000436683.2 ENST00000574876.1 |
PELP1
|
proline, glutamate and leucine rich protein 1 |
| chr10_-_76995769 | 5.09 |
ENST00000372538.3
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr16_-_54963026 | 5.09 |
ENST00000560208.1
ENST00000557792.1 |
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding) |
| chr20_-_17949363 | 5.06 |
ENST00000377759.4
ENST00000606557.1 ENST00000606602.1 ENST00000486039.1 ENST00000481323.1 |
SNX5
|
sorting nexin 5 |
| chr15_-_27018884 | 5.06 |
ENST00000299267.4
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chrX_-_100604184 | 5.06 |
ENST00000372902.3
|
TIMM8A
|
translocase of inner mitochondrial membrane 8 homolog A (yeast) |
| chr10_+_101542462 | 5.05 |
ENST00000370449.4
ENST00000370434.1 |
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
| chr21_-_44299626 | 5.05 |
ENST00000330317.2
ENST00000398208.2 |
WDR4
|
WD repeat domain 4 |
| chr12_-_112450915 | 5.04 |
ENST00000437003.2
ENST00000552374.2 ENST00000550831.3 ENST00000354825.3 ENST00000549537.2 ENST00000355445.3 |
TMEM116
|
transmembrane protein 116 |
| chr7_-_134143841 | 5.03 |
ENST00000285930.4
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
| chr15_-_83316711 | 5.02 |
ENST00000568128.1
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr11_-_86383157 | 5.01 |
ENST00000393324.3
|
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial |
| chr17_+_49243639 | 4.99 |
ENST00000512737.1
ENST00000503064.1 |
NME1-NME2
|
NME1-NME2 readthrough |
| chr15_+_69591235 | 4.98 |
ENST00000395407.2
ENST00000558684.1 |
PAQR5
|
progestin and adipoQ receptor family member V |
| chr11_+_66624527 | 4.95 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
| chr7_-_27179814 | 4.94 |
ENST00000522788.1
ENST00000521779.1 |
HOXA3
|
homeobox A3 |
| chr12_-_64616019 | 4.91 |
ENST00000311915.8
ENST00000398055.3 ENST00000544871.1 |
C12orf66
|
chromosome 12 open reading frame 66 |
| chr12_-_49523896 | 4.90 |
ENST00000549870.1
|
TUBA1B
|
tubulin, alpha 1b |
| chr8_-_61193947 | 4.89 |
ENST00000317995.4
|
CA8
|
carbonic anhydrase VIII |
| chr21_+_46875424 | 4.88 |
ENST00000359759.4
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chrX_+_118108571 | 4.86 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
| chr7_-_150780609 | 4.86 |
ENST00000297533.4
|
TMUB1
|
transmembrane and ubiquitin-like domain containing 1 |
| chr22_-_22901636 | 4.82 |
ENST00000406503.1
ENST00000439106.1 ENST00000402697.1 ENST00000543184.1 ENST00000398743.2 |
PRAME
|
preferentially expressed antigen in melanoma |
| chr21_+_46875395 | 4.79 |
ENST00000355480.5
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chr19_-_8373173 | 4.79 |
ENST00000537716.2
ENST00000301458.5 |
CD320
|
CD320 molecule |
| chr16_-_87903079 | 4.79 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr9_-_6645628 | 4.76 |
ENST00000321612.6
|
GLDC
|
glycine dehydrogenase (decarboxylating) |
| chr15_-_68521996 | 4.75 |
ENST00000418702.2
ENST00000565471.1 ENST00000564752.1 ENST00000566347.1 ENST00000249806.5 ENST00000562767.1 |
CLN6
RP11-315D16.2
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant Uncharacterized protein |
Network of associatons between targets according to the STRING database.
First level regulatory network of MXI1_MYC_MYCN
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 15.9 | GO:0007412 | axon target recognition(GO:0007412) |
| 5.0 | 24.8 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 4.7 | 19.0 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 3.9 | 11.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 3.7 | 14.8 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 3.3 | 13.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 3.3 | 9.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 3.2 | 15.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 3.1 | 9.3 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 3.1 | 15.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 3.0 | 9.0 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 2.9 | 11.6 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 2.8 | 19.4 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 2.7 | 13.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 2.5 | 17.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 2.5 | 7.5 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 2.5 | 9.9 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 2.5 | 7.4 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 2.3 | 6.9 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 2.3 | 20.4 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 2.2 | 6.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 2.1 | 8.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 2.1 | 2.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 2.1 | 10.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 2.1 | 8.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 2.0 | 6.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 2.0 | 20.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 2.0 | 4.0 | GO:0048708 | astrocyte differentiation(GO:0048708) |
| 2.0 | 5.9 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 1.9 | 5.8 | GO:0035570 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 1.9 | 13.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 1.9 | 13.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 1.9 | 5.7 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 1.9 | 15.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 1.9 | 15.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 1.9 | 9.3 | GO:0015862 | uridine transport(GO:0015862) |
| 1.8 | 10.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 1.7 | 5.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 1.7 | 8.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.7 | 5.2 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 1.7 | 18.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.7 | 5.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 1.7 | 3.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 1.7 | 6.8 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 1.7 | 13.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 1.7 | 6.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 1.7 | 1.7 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 1.6 | 4.9 | GO:0010159 | specification of organ position(GO:0010159) |
| 1.6 | 4.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.6 | 12.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.6 | 6.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 1.5 | 6.2 | GO:0006788 | heme oxidation(GO:0006788) negative regulation of mast cell cytokine production(GO:0032764) |
| 1.5 | 12.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 1.5 | 27.6 | GO:0030238 | male sex determination(GO:0030238) |
| 1.5 | 6.1 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.5 | 21.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 1.5 | 4.5 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 1.5 | 8.9 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 1.5 | 5.9 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 1.5 | 4.4 | GO:0061010 | gall bladder development(GO:0061010) |
| 1.5 | 14.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 1.5 | 4.4 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 1.4 | 7.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 1.4 | 7.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.4 | 17.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 1.4 | 5.7 | GO:1903566 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
| 1.4 | 8.6 | GO:0072197 | ureter morphogenesis(GO:0072197) |
| 1.4 | 5.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 1.4 | 2.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.4 | 5.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.4 | 5.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 1.4 | 1.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 1.4 | 12.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 1.4 | 4.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 1.4 | 2.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.3 | 6.7 | GO:0031296 | B cell costimulation(GO:0031296) |
| 1.3 | 8.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 1.3 | 5.3 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.3 | 3.9 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 1.3 | 12.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 1.2 | 6.2 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 1.2 | 1.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 1.2 | 14.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 1.2 | 6.1 | GO:0035106 | operant conditioning(GO:0035106) |
| 1.2 | 24.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 1.2 | 3.6 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 1.2 | 1.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
| 1.2 | 7.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 1.2 | 4.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.1 | 5.6 | GO:0003285 | septum secundum development(GO:0003285) |
| 1.1 | 7.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 1.1 | 5.5 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 1.1 | 13.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 1.1 | 4.3 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 1.1 | 4.3 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 1.1 | 3.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 1.0 | 3.1 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 1.0 | 6.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 1.0 | 2.0 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 1.0 | 10.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 1.0 | 4.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.0 | 16.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 1.0 | 4.8 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 1.0 | 1.0 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 1.0 | 9.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.9 | 2.8 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.9 | 5.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.9 | 2.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.9 | 3.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.9 | 7.2 | GO:0050893 | sensory processing(GO:0050893) |
| 0.9 | 2.7 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.9 | 2.7 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.9 | 2.7 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.9 | 5.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.9 | 1.8 | GO:0060197 | cloacal septation(GO:0060197) |
| 0.9 | 1.8 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of fibroblast growth factor production(GO:0090271) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.9 | 2.6 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.9 | 2.6 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 0.9 | 7.0 | GO:0021546 | rhombomere development(GO:0021546) |
| 0.9 | 2.6 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.9 | 12.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.9 | 3.5 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.9 | 5.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.9 | 8.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.9 | 10.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.8 | 5.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.8 | 3.3 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.8 | 3.3 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.8 | 2.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.8 | 3.2 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.8 | 3.1 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.8 | 2.3 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.8 | 4.6 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.8 | 4.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.8 | 0.8 | GO:0044256 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.8 | 3.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.8 | 1.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.7 | 3.7 | GO:2000051 | Wnt receptor catabolic process(GO:0038018) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.7 | 7.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.7 | 2.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.7 | 2.9 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.7 | 5.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.7 | 8.7 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.7 | 4.3 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.7 | 2.2 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 0.7 | 7.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.7 | 7.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.7 | 3.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.7 | 6.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.7 | 5.5 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.7 | 2.0 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.7 | 2.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.7 | 2.0 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.7 | 7.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.7 | 2.0 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.7 | 2.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.7 | 2.6 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.7 | 2.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.7 | 2.6 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.6 | 2.6 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.6 | 1.9 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.6 | 2.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.6 | 3.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.6 | 5.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.6 | 1.9 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 0.6 | 2.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.6 | 13.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.6 | 2.5 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.6 | 1.8 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.6 | 4.9 | GO:0045007 | depurination(GO:0045007) |
| 0.6 | 2.5 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.6 | 1.8 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.6 | 3.7 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.6 | 2.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.6 | 9.7 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.6 | 11.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.6 | 1.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.6 | 4.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.6 | 7.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.6 | 5.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.6 | 2.9 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.6 | 4.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.6 | 9.9 | GO:0035878 | nail development(GO:0035878) |
| 0.6 | 2.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.6 | 0.6 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.6 | 4.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.6 | 11.0 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.6 | 2.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.6 | 1.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.6 | 2.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.6 | 5.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.6 | 5.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.6 | 4.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.6 | 0.6 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.6 | 1.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.6 | 12.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.6 | 2.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.6 | 10.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.5 | 2.2 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.5 | 8.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.5 | 2.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.5 | 6.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.5 | 3.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.5 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.5 | 0.5 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 0.5 | 2.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.5 | 1.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.5 | 1.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.5 | 7.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.5 | 2.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.5 | 1.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.5 | 2.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.5 | 3.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.5 | 3.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.5 | 1.6 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.5 | 4.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.5 | 3.0 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 0.5 | 2.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.5 | 4.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.5 | 4.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.5 | 3.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 | 1.5 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.5 | 6.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.5 | 8.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.5 | 14.5 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.5 | 5.0 | GO:0015677 | copper ion import(GO:0015677) |
| 0.5 | 4.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.5 | 2.9 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.5 | 3.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.5 | 1.9 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.5 | 1.5 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.5 | 9.2 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.5 | 20.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.5 | 1.4 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 0.5 | 2.8 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.5 | 7.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.5 | 1.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.5 | 10.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.5 | 2.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.5 | 2.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.5 | 3.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.5 | 8.7 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.4 | 4.4 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.4 | 2.2 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.4 | 3.5 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.4 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.4 | 10.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.4 | 2.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.4 | 3.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.4 | 2.6 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.4 | 1.7 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.4 | 3.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.4 | 1.7 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.4 | 4.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.4 | 15.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.4 | 1.7 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.4 | 1.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.4 | 3.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.4 | 2.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.4 | 6.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 | 2.8 | GO:0019075 | virus maturation(GO:0019075) |
| 0.4 | 4.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.4 | 3.2 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.4 | 6.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.4 | 1.6 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.4 | 6.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.4 | 0.8 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.4 | 5.1 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.4 | 2.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.4 | 9.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.4 | 2.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.4 | 2.3 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.4 | 1.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.4 | 14.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.4 | 4.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.4 | 1.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.4 | 1.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.4 | 0.7 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.4 | 3.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.4 | 0.7 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.4 | 6.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 | 1.8 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.4 | 5.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 | 3.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 | 1.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.4 | 1.5 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.4 | 1.1 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.4 | 0.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.4 | 1.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.4 | 1.4 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.4 | 0.7 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.4 | 1.8 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 0.4 | 0.7 | GO:0043132 | NAD transport(GO:0043132) |
| 0.4 | 1.1 | GO:0045553 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.3 | 1.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 | 0.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 2.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.3 | 6.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 | 6.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.3 | 2.8 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.3 | 2.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.3 | 1.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.3 | 1.4 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.3 | 13.5 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
| 0.3 | 1.7 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 0.3 | 6.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.3 | 5.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 1.0 | GO:0035989 | tendon development(GO:0035989) |
| 0.3 | 1.3 | GO:0061743 | motor learning(GO:0061743) |
| 0.3 | 1.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.3 | 1.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.3 | 0.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.3 | 2.9 | GO:1990034 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export from cell(GO:1990034) |
| 0.3 | 2.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.3 | 9.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.3 | 2.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.3 | 1.3 | GO:0051598 | meiotic recombination checkpoint(GO:0051598) |
| 0.3 | 2.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 | 1.0 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.3 | 0.6 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
| 0.3 | 6.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.3 | 3.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 | 1.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 | 1.6 | GO:0052148 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.3 | 33.6 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.3 | 1.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.3 | 1.5 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 | 3.0 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 1.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 | 1.5 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.3 | 2.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 | 0.6 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.3 | 3.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.3 | 3.0 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.3 | 2.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 | 1.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.3 | 0.9 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.3 | 4.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.3 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.3 | 2.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.3 | 0.6 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.3 | 8.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.3 | 2.0 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 | 0.6 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
| 0.3 | 2.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 | 0.8 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.3 | 14.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.3 | 1.1 | GO:0018277 | protein deamination(GO:0018277) |
| 0.3 | 2.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 | 3.1 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.3 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
| 0.3 | 1.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.3 | 1.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.3 | 2.7 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.3 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.3 | 3.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.3 | 3.8 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.3 | 2.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.3 | 7.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.3 | 1.9 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.3 | 2.9 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.3 | 1.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 | 2.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 | 0.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.3 | 6.6 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.3 | 1.0 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.3 | 1.6 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.3 | 2.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.3 | 0.8 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.3 | 7.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.3 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 | 1.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.3 | 2.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.3 | 0.3 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.3 | 1.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.3 | 2.8 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.3 | 0.8 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.3 | 0.8 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 | 0.8 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.3 | 5.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.3 | 5.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.3 | 1.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.3 | 1.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.3 | 4.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 | 3.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.2 | 0.2 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.2 | 0.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 | 0.2 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
| 0.2 | 4.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 | 4.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 0.7 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.2 | 2.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.2 | 1.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.2 | 1.4 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.2 | 1.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.2 | 6.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.2 | 1.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.2 | 1.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.2 | 0.7 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.2 | 4.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.2 | 1.9 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.2 | 4.5 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 0.9 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.2 | 25.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.2 | 1.2 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 | 7.6 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 3.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.2 | 1.1 | GO:0042262 | DNA protection(GO:0042262) |
| 0.2 | 10.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
| 0.2 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.2 | 1.6 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 8.2 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.2 | 1.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.2 | 5.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.2 | 0.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 | 0.4 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.2 | 0.7 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.2 | 0.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 | 8.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.2 | 2.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.2 | 0.9 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 | 1.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 1.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 0.6 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.2 | 2.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.2 | 0.9 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 | 1.5 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.2 | 5.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.2 | 1.1 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of glial cell migration(GO:1903977) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.2 | 1.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.2 | 11.7 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.2 | 8.3 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.2 | 1.0 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.2 | 0.8 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.2 | 0.6 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.2 | 0.4 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.2 | 3.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.2 | 3.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.2 | 5.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 1.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.2 | 4.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 0.8 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.2 | 0.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.2 | 0.8 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 | 1.4 | GO:0060356 | leucine import(GO:0060356) |
| 0.2 | 4.0 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
| 0.2 | 1.8 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.2 | 2.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 | 0.6 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.2 | 1.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 | 1.0 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 | 0.8 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.2 | 3.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.2 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 1.4 | GO:0032328 | alanine transport(GO:0032328) |
| 0.2 | 0.6 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.2 | 1.4 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 | 1.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 0.8 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.2 | 1.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 1.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 1.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.2 | 3.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 16.3 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 | 1.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.2 | 1.3 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.2 | 0.2 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.2 | 3.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 4.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 | 0.4 | GO:0052501 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.2 | 1.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 0.7 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.2 | 8.3 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.2 | 1.4 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.2 | 0.4 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.2 | 0.4 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 0.2 | 0.7 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 1.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 | 0.7 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 10.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.2 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.2 | 0.7 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.2 | 0.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.2 | 6.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.2 | 0.5 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.2 | 1.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 1.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 | 4.7 | GO:0018126 | protein hydroxylation(GO:0018126) |
| 0.2 | 5.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 | 0.7 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.2 | 0.8 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.2 | 1.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.2 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.2 | 0.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 1.0 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.2 | 0.8 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.2 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.2 | 1.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 | 1.3 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.2 | 4.4 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.2 | 2.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 | 0.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.2 | 0.3 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.2 | 0.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.2 | 3.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 1.9 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 2.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 | 1.9 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.2 | 1.9 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.2 | 7.0 | GO:0006414 | translational elongation(GO:0006414) |
| 0.2 | 0.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 | 1.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 6.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.2 | 2.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.2 | 0.8 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 | 0.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.2 | 1.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.2 | 2.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 | 2.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.2 | 1.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.2 | 2.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 | 3.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 2.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.1 | 0.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 | 5.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.1 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 2.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.1 | 0.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 | 1.5 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 3.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 2.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.6 | GO:0086028 | Purkinje myocyte action potential(GO:0086017) bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.1 | 1.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 | 0.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 1.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 3.6 | GO:0097502 | mannosylation(GO:0097502) |
| 0.1 | 7.2 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.7 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.1 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
| 0.1 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 1.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.7 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 2.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.1 | 1.1 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.1 | 1.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 | 0.9 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 0.9 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 | 0.7 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
| 0.1 | 1.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 | 0.5 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
| 0.1 | 3.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 4.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.1 | 0.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 | 0.5 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.1 | 15.7 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.1 | 0.3 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) |
| 0.1 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.9 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 2.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 13.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 1.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 1.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.1 | 2.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 1.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.9 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.1 | 2.4 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 | 1.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
| 0.1 | 2.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 | 1.0 | GO:0045837 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
| 0.1 | 0.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.1 | 1.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 | 4.1 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 1.1 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.1 | 0.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.9 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.1 | 1.6 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.1 | 1.7 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.1 | 0.4 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.6 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.1 | 0.2 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.1 | 1.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 | 0.5 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 0.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 | 0.8 | GO:0016233 | telomere capping(GO:0016233) |
| 0.1 | 2.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.1 | 0.6 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.1 | 1.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.1 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.3 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 | 12.9 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.1 | 4.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 4.5 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 2.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 5.3 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.1 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 | 1.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 | 0.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 1.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 1.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 | 0.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.1 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.1 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 | 2.7 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.1 | 0.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 | 2.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 | 0.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.1 | 3.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
| 0.1 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 2.7 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.1 | 0.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 0.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 | 0.9 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.1 | 2.7 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 0.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 1.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 | 0.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 | 2.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 1.9 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 0.5 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.1 | 5.1 | GO:0009880 | embryonic pattern specification(GO:0009880) |
| 0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) regulation of determination of dorsal identity(GO:2000015) |
| 0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 | 2.6 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.1 | 6.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.1 | 1.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.2 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 0.1 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 1.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.1 | 1.4 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 1.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.1 | 0.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.1 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.1 | 10.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 6.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.5 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 1.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 4.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.1 | 0.3 | GO:0085020 | protein K27-linked ubiquitination(GO:0044314) protein K6-linked ubiquitination(GO:0085020) |
| 0.1 | 1.0 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 | 0.3 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.1 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.1 | 0.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 1.7 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 | 0.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.1 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 | 0.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 | 1.0 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.1 | 0.4 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
| 0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
| 0.1 | 0.1 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.1 | 3.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 2.5 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.2 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.1 | 1.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.1 | 1.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 2.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.1 | 2.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.1 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 1.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 1.3 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
| 0.1 | 1.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 0.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 0.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 1.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 1.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.1 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 1.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.2 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 0.7 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.1 | GO:0045623 | negative regulation of T-helper cell differentiation(GO:0045623) |
| 0.1 | 2.0 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.1 | 0.6 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.1 | 0.3 | GO:0033274 | response to vitamin B2(GO:0033274) chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.1 | 2.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.1 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
| 0.1 | 0.3 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.1 | 1.4 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 2.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.1 | 0.6 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 0.7 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
| 0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 0.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 | 0.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 0.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 | 0.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 2.1 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.1 | 0.3 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 0.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 0.5 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
| 0.1 | 0.3 | GO:1900274 | positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
| 0.1 | 0.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 1.5 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.1 | 1.6 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 | 0.8 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.1 | 1.9 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.1 | 0.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 0.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 1.8 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.1 | 0.4 | GO:0019054 | modulation by virus of host process(GO:0019054) |
| 0.1 | 12.6 | GO:0006457 | protein folding(GO:0006457) |
| 0.1 | 0.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 | 0.2 | GO:0071348 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
| 0.1 | 0.4 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 2.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.0 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.0 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.0 | 0.8 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.0 | 1.6 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 | 0.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 | 1.0 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 | 0.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.0 | 8.8 | GO:0010038 | response to metal ion(GO:0010038) |
| 0.0 | 0.5 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 2.9 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.0 | 0.3 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.0 | 0.4 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.0 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 | 0.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.0 | 0.2 | GO:1901374 | acetate ester transport(GO:1901374) |
| 0.0 | 2.9 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.0 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.0 | 0.1 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 | 0.2 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 | 0.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.6 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 | 3.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 2.8 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 1.7 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 | 0.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 | 0.1 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.0 | 0.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.9 | GO:0050881 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.0 | 0.6 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 | 0.0 | GO:0042320 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.0 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 | 0.1 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.0 | 0.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.0 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 | 0.6 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
| 0.0 | 0.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 | 0.9 | GO:0061053 | somite development(GO:0061053) |
| 0.0 | 0.2 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 | 1.9 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.0 | 0.7 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
| 0.0 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.2 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.0 | 0.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 | 0.3 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.0 | 0.1 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 | 0.4 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
| 0.0 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.0 | 0.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.0 | 0.4 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 | 0.2 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
| 0.0 | 0.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 | 1.7 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 | 0.2 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.1 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 | 0.4 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.0 | 0.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.0 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 1.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.0 | 0.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 | 0.4 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 1.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
| 0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 1.0 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
| 0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 | 0.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.0 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.0 | 0.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.0 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.1 | GO:0060369 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.0 | 0.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.0 | 0.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.1 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.0 | 0.2 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.2 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.0 | 0.5 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.4 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.0 | 0.1 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.0 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.0 | 0.2 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.0 | 0.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 | 0.1 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.0 | 0.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 | 0.0 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.0 | 0.3 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 | 0.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 | 0.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.0 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 15.9 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 4.7 | 14.2 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 3.8 | 18.8 | GO:0070701 | mucus layer(GO:0070701) |
| 3.0 | 15.0 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 2.2 | 18.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 2.1 | 17.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 2.1 | 27.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 1.9 | 14.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.7 | 5.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 1.7 | 13.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.6 | 14.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 1.5 | 22.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 1.5 | 23.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.5 | 4.4 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 1.3 | 18.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 1.3 | 5.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 1.2 | 8.3 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 1.1 | 8.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 1.1 | 14.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.1 | 5.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 1.1 | 24.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 1.1 | 3.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 1.0 | 9.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.9 | 4.7 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.9 | 18.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.9 | 4.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.9 | 4.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.8 | 4.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.8 | 4.0 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.8 | 5.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.7 | 6.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.7 | 3.6 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.7 | 2.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.7 | 9.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.7 | 10.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.7 | 2.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.7 | 4.0 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.7 | 6.7 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.7 | 2.0 | GO:0035101 | FACT complex(GO:0035101) |
| 0.6 | 3.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.6 | 7.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.6 | 7.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.6 | 3.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.6 | 5.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.6 | 3.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.6 | 5.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.6 | 2.8 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.5 | 3.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.5 | 2.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.5 | 5.2 | GO:0033503 | HULC complex(GO:0033503) |
| 0.5 | 0.5 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.5 | 1.5 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.5 | 1.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.5 | 1.4 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 0.5 | 8.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.5 | 6.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.5 | 7.9 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.4 | 17.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.4 | 3.4 | GO:0097361 | CIA complex(GO:0097361) |
| 0.4 | 1.3 | GO:0034657 | GID complex(GO:0034657) |
| 0.4 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.4 | 1.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.4 | 2.9 | GO:0098536 | deuterosome(GO:0098536) |
| 0.4 | 14.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.4 | 15.9 | GO:0043218 | compact myelin(GO:0043218) |
| 0.4 | 1.6 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.4 | 3.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.4 | 3.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.4 | 3.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.4 | 5.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.4 | 2.9 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.4 | 1.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.4 | 11.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.4 | 9.1 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 2.5 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.4 | 1.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.4 | 3.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.3 | 2.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.3 | 3.8 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.3 | 4.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.3 | 10.3 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.3 | 2.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.3 | 1.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.3 | 5.1 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.3 | 6.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.3 | 3.1 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.3 | 5.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.3 | 8.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.3 | 8.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.3 | 7.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.3 | 5.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.3 | 7.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.3 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.3 | 4.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.3 | 0.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.3 | 1.0 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.3 | 6.8 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 1.2 | GO:0000938 | GARP complex(GO:0000938) |
| 0.2 | 3.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 1.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.2 | 1.0 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.2 | 2.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 1.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.2 | 4.8 | GO:0032059 | bleb(GO:0032059) |
| 0.2 | 3.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.2 | 2.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 4.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 2.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.2 | 2.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 2.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 1.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.2 | 7.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.2 | 5.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 2.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 2.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.2 | 11.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.2 | 3.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 2.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 0.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 1.5 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 1.3 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.2 | 0.6 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.2 | 2.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.2 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 1.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 0.8 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.2 | 4.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 2.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.2 | 14.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.2 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
| 0.2 | 2.5 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.2 | 0.8 | GO:0060187 | cell pole(GO:0060187) |
| 0.2 | 21.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 1.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.2 | 4.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 3.9 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.2 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.2 | 2.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.2 | 2.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 2.5 | GO:0001741 | XY body(GO:0001741) |
| 0.2 | 15.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 1.4 | GO:0000805 | X chromosome(GO:0000805) Barr body(GO:0001740) |
| 0.2 | 3.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 3.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 5.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.2 | 16.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 4.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 2.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.2 | 9.8 | GO:0005657 | replication fork(GO:0005657) |
| 0.2 | 0.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.2 | 13.1 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 0.5 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.2 | 1.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 0.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.2 | 5.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 10.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.2 | 10.3 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 2.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 0.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 3.6 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.4 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.1 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 1.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 1.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 4.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 10.6 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 0.6 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 3.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 1.0 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.1 | 10.7 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.1 | 4.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 0.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 1.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 0.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 16.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 0.5 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 15.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 14.0 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 2.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 1.8 | GO:0042627 | chylomicron(GO:0042627) |
| 0.1 | 1.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 1.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 0.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.1 | 7.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 1.5 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 22.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 2.5 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 1.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 1.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 1.0 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 1.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 0.2 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 1.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 6.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 2.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 8.6 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 2.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 6.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 0.4 | GO:0097196 | Shu complex(GO:0097196) |
| 0.1 | 4.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 0.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 11.6 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 0.9 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 2.4 | GO:0097346 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
| 0.1 | 0.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.1 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 1.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 2.1 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 0.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 1.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 42.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 1.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 2.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 5.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 5.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 9.6 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 1.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 11.4 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 27.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 8.9 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.1 | 0.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 0.3 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 1.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 4.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 3.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 107.0 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.1 | 1.6 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.1 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 1.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 3.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 3.6 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 3.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 6.8 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 3.6 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.0 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.0 | 0.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.0 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 2.0 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.0 | 0.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.0 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
| 0.0 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.0 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 1.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
| 0.0 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.0 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.0 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.0 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.0 | 2.4 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
| 0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 1.6 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 6.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 1.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.1 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.0 | 1.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 0.7 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 6.2 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 2.2 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.0 | 130.9 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 1.4 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.0 | 0.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 7.2 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.0 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.0 | 0.2 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.2 | 15.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 4.5 | 13.4 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 4.1 | 16.6 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 4.0 | 15.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 2.9 | 2.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 2.8 | 8.5 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 2.8 | 25.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 2.8 | 11.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 2.7 | 8.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.7 | 13.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 2.7 | 15.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 2.5 | 7.5 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 2.4 | 7.2 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 2.3 | 7.0 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 2.3 | 11.6 | GO:0070905 | serine binding(GO:0070905) |
| 2.3 | 6.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 2.2 | 6.5 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 2.1 | 14.8 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 2.1 | 8.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 2.0 | 8.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 2.0 | 6.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 1.9 | 9.3 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 1.8 | 5.5 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 1.6 | 4.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 1.6 | 4.8 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 1.6 | 4.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 1.6 | 6.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 1.6 | 7.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.6 | 4.7 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 1.5 | 6.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 1.5 | 6.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 1.5 | 4.5 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 1.5 | 8.9 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 1.5 | 8.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 1.5 | 5.8 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 1.5 | 4.4 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 1.4 | 4.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 1.4 | 14.9 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 1.4 | 5.4 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 1.3 | 4.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 1.3 | 5.3 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 1.3 | 4.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 1.3 | 7.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 1.3 | 3.9 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 1.3 | 11.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 1.3 | 11.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 1.2 | 6.2 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 1.2 | 6.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 1.2 | 1.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 1.2 | 5.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 1.1 | 23.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 1.1 | 3.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 1.1 | 6.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 1.1 | 3.2 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
| 1.1 | 3.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 1.1 | 4.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 1.1 | 19.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 1.0 | 17.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 1.0 | 4.2 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 1.0 | 14.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 1.0 | 3.1 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 1.0 | 8.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 1.0 | 8.6 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
| 1.0 | 4.8 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.9 | 2.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.9 | 9.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.9 | 5.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.9 | 4.5 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.9 | 2.7 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.9 | 2.7 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.9 | 36.4 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.9 | 2.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.9 | 3.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.9 | 6.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.8 | 3.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.8 | 2.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.8 | 8.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.8 | 5.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.8 | 5.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.8 | 3.2 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.8 | 13.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.8 | 1.6 | GO:0045142 | triplex DNA binding(GO:0045142) |
| 0.8 | 8.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.8 | 2.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.8 | 3.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.8 | 3.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.8 | 3.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.8 | 3.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.8 | 3.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.8 | 2.3 | GO:0019862 | IgA binding(GO:0019862) |
| 0.7 | 6.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.7 | 1.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.7 | 2.9 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.7 | 5.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.7 | 15.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.7 | 4.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.7 | 8.6 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.7 | 7.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.7 | 2.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.7 | 2.8 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.7 | 0.7 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.7 | 7.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.7 | 13.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.7 | 2.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.7 | 4.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.7 | 4.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.7 | 20.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.7 | 6.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.7 | 8.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.7 | 10.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.7 | 15.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.7 | 2.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.6 | 2.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.6 | 18.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.6 | 1.9 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.6 | 16.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.6 | 3.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.6 | 2.5 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 0.6 | 1.8 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.6 | 2.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.6 | 5.4 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.6 | 1.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.6 | 11.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.6 | 2.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.6 | 2.3 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.6 | 2.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.6 | 0.6 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.6 | 3.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.6 | 1.7 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.6 | 1.7 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.6 | 2.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.6 | 5.0 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.6 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.6 | 1.7 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.6 | 4.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.5 | 6.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.5 | 2.6 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.5 | 3.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.5 | 1.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.5 | 1.6 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.5 | 19.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.5 | 1.6 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.5 | 9.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.5 | 2.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.5 | 1.5 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.5 | 8.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.5 | 1.5 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.5 | 3.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.5 | 1.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.5 | 8.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.5 | 1.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.5 | 3.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.5 | 5.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.5 | 1.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.5 | 2.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.5 | 1.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.5 | 1.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.5 | 1.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.5 | 1.8 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.5 | 3.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.4 | 3.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.4 | 1.3 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.4 | 4.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.4 | 1.8 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.4 | 6.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.4 | 2.2 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.4 | 1.3 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.4 | 1.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.4 | 1.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.4 | 2.1 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.4 | 9.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.4 | 5.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.4 | 4.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.4 | 2.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.4 | 5.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.4 | 6.6 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.4 | 2.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.4 | 6.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.4 | 2.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.4 | 2.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.4 | 4.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.4 | 4.3 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.4 | 19.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.4 | 5.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.4 | 2.7 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.4 | 3.9 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.4 | 1.9 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.4 | 3.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.4 | 1.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.4 | 6.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.4 | 4.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.4 | 1.5 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.4 | 2.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.4 | 1.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.4 | 2.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.4 | 3.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.4 | 2.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.4 | 1.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.4 | 3.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.4 | 1.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.4 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.4 | 1.1 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.4 | 12.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 1.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.4 | 18.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.4 | 4.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.4 | 1.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.3 | 33.1 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.3 | 3.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.3 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 8.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.3 | 25.2 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.3 | 1.0 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.3 | 1.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 1.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.3 | 3.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.3 | 3.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.3 | 1.7 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.3 | 10.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.3 | 16.3 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.3 | 7.3 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.3 | 1.3 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.3 | 3.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 3.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.3 | 4.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.3 | 1.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.3 | 7.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.3 | 17.7 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.3 | 1.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.3 | 0.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.3 | 2.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.3 | 10.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.3 | 0.9 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.3 | 3.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 3.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.3 | 9.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 5.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.3 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.3 | 1.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.3 | 0.9 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.3 | 0.9 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.3 | 3.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.3 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 3.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.3 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.3 | 22.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.3 | 2.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.3 | 2.2 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.3 | 1.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.3 | 0.8 | GO:0052835 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.3 | 1.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.3 | 1.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.3 | 3.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.3 | 1.9 | GO:0070513 | death domain binding(GO:0070513) |
| 0.3 | 2.2 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.3 | 2.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.3 | 15.2 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.3 | 1.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.3 | 7.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.3 | 0.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.3 | 3.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 3.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.3 | 0.8 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.3 | 1.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.3 | 1.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.3 | 2.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.3 | 0.8 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.3 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.3 | 6.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.3 | 1.5 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 1.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.3 | 0.8 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.3 | 13.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 1.2 | GO:0033265 | choline binding(GO:0033265) |
| 0.2 | 1.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.2 | 5.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.2 | 1.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 0.7 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.2 | 1.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.2 | 2.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 4.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 10.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 5.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.2 | 2.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.2 | 2.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 3.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 0.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.2 | 0.7 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.2 | 0.4 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 1.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.2 | 1.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.2 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.2 | 49.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 1.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 1.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.2 | 1.5 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.2 | 1.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.2 | 1.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 6.5 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.2 | 1.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.2 | 6.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 1.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.2 | 2.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.2 | 5.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.2 | 3.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.2 | 4.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.2 | 2.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 0.6 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.2 | 1.0 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.2 | 2.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.2 | 2.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.2 | 2.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.2 | 6.8 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 0.6 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.2 | 11.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.2 | 1.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.2 | 1.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.2 | 0.8 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.2 | 7.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.2 | 0.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.2 | 1.3 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.2 | 1.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 1.8 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 0.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.2 | 0.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.2 | 2.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.2 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.2 | 0.7 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.2 | 1.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 5.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 2.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 3.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.2 | 3.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 0.7 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.2 | 1.0 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 1.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.2 | 1.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.2 | 1.4 | GO:0050661 | NADP binding(GO:0050661) |
| 0.2 | 1.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.2 | 9.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.2 | 2.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 1.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.2 | 13.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.2 | 2.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.2 | 2.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 0.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.2 | 3.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.2 | 1.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.2 | 1.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 1.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.2 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.2 | 4.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.2 | 8.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.2 | 4.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.2 | 0.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.2 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.2 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.2 | 2.0 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.1 | 19.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.1 | 4.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 2.8 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.1 | 0.4 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.1 | 0.4 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.1 | 1.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 1.0 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 0.6 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.1 | 4.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 0.6 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 1.5 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 2.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.1 | 6.7 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 1.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 1.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 1.7 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 0.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.1 | 1.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.1 | 3.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.1 | 13.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 6.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.4 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.1 | 2.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 2.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.1 | 4.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.3 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.1 | 3.5 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.1 | 3.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 1.3 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 1.1 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.1 | 0.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 1.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 0.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.1 | 0.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 3.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 6.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 0.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.1 | 0.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 1.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 2.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 4.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 0.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.1 | 1.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.3 | GO:0034714 | type II transforming growth factor beta receptor binding(GO:0005114) type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.1 | 0.4 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.1 | 2.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 8.6 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
| 0.1 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 3.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 9.2 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 1.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 1.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 4.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.1 | 1.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.1 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.1 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.1 | 3.9 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.1 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 0.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 2.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 3.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 1.2 | GO:0004175 | endopeptidase activity(GO:0004175) |
| 0.1 | 5.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.1 | 2.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 1.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 1.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.1 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 7.8 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.1 | 0.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 5.0 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 1.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 5.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.1 | 1.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 4.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 1.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 12.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.3 | GO:0099528 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
| 0.1 | 1.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 2.3 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 0.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.0 | 1.2 | GO:0008233 | peptidase activity(GO:0008233) |
| 0.0 | 5.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.0 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.0 | 1.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 2.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.0 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
| 0.0 | 0.3 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.0 | 1.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.0 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.0 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.0 | 1.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.0 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.0 | 0.2 | GO:0015651 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.0 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.0 | 0.8 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
| 0.0 | 0.3 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.0 | 3.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.0 | 0.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.0 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.0 | 7.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 1.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 3.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 3.6 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.0 | 0.1 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
| 0.0 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.0 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.0 | 0.2 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 0.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.0 | 2.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.7 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.0 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 1.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 2.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.0 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.0 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.0 | 0.8 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
| 0.0 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 0.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.0 | 1.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.0 | 0.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.0 | 0.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
| 0.0 | 1.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.0 | 0.1 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.0 | 0.1 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.1 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.0 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 0.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.0 | 1.3 | GO:0019838 | growth factor binding(GO:0019838) |
| 0.0 | 0.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.0 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 0.3 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
| 0.0 | 0.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 1.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.0 | 4.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 3.4 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.7 | 7.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.6 | 16.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.5 | 11.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.4 | 11.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.4 | 8.6 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.4 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.4 | 9.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.3 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.3 | 24.3 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.3 | 13.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 13.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 10.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 4.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 3.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 1.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 0.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.2 | 5.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.2 | 8.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.2 | 5.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 9.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 2.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 5.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.2 | 18.3 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.2 | 8.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.2 | 16.0 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 17.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 11.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.2 | 12.3 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 7.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 8.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 13.6 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 2.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 3.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 5.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 6.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 3.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 1.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 0.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 6.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 3.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 3.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 7.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 6.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 5.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 3.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 3.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 4.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.1 | 3.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 7.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 1.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 2.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 3.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 2.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 2.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 2.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 0.8 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 1.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 1.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 1.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 6.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 4.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 1.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 2.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 1.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 2.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.1 | 2.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 2.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.0 | 11.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 2.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.0 | 2.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 2.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 1.1 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 1.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 2.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 1.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 22.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.0 | 15.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.8 | 1.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.8 | 1.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.7 | 17.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.7 | 30.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.6 | 47.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.6 | 14.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.6 | 11.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.6 | 11.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.6 | 1.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.5 | 11.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.5 | 23.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.5 | 18.9 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.5 | 11.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.5 | 7.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.5 | 10.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.5 | 3.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.4 | 18.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.4 | 4.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.4 | 36.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.4 | 24.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.4 | 31.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.4 | 7.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.4 | 0.8 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.4 | 17.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.4 | 10.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.4 | 29.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.3 | 21.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.3 | 9.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.3 | 6.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 2.0 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.3 | 4.5 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.3 | 21.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.3 | 5.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.3 | 5.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.3 | 26.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.3 | 9.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.3 | 7.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.3 | 6.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.3 | 8.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.3 | 5.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.3 | 1.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.3 | 8.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.3 | 7.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.3 | 5.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.3 | 4.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.2 | 4.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 5.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.2 | 27.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 5.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 4.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.2 | 4.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.2 | 4.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.2 | 10.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 0.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 5.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.2 | 7.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.2 | 5.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.2 | 5.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 0.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.2 | 12.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 3.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 6.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 3.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 3.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 1.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.2 | 5.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 8.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 5.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 7.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 5.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 18.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 2.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 2.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 5.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.2 | 5.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 3.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 5.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.2 | 1.8 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
| 0.1 | 9.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 14.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 8.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.1 | 1.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 7.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 10.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 2.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 14.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.1 | 3.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 9.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.1 | 4.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 2.6 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
| 0.1 | 0.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 1.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 5.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 2.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.1 | 3.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 8.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 4.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 1.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 3.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 6.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 6.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 3.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 3.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 2.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.1 | 2.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 1.8 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 2.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.1 | 2.8 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 0.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 3.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 1.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 2.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 5.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 2.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 10.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.1 | 1.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 1.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 2.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.1 | 2.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.1 | 9.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 1.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 1.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 1.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.0 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.0 | 2.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.0 | 1.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 1.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.0 | 1.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 1.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 2.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.6 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| 0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |